Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States (Q41619464)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States |
scientific article |
Statements
1 reference
Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States (English)
1 reference
Thomas E Delea
1 reference
Jordan Amdahl
1 reference
Jose Diaz
1 reference
Hamid Reza Nakhaipour
1 reference
Michelle D Hackshaw
1 reference
1 January 2015
1 reference
1 reference